Same ingredient, two names · semaglutide
Ozempic vs Rybelsus
From the two FDA labels, read Published by PepVault
Ozempic and Rybelsus are the same medicine, semaglutide, under two names from Novo Nordisk.
What differs is the label. FDA approved Ozempic for blood sugar control in adults with type 2 diabetes, and lowering heart and kidney risks in some of them. Rybelsus is approved for blood sugar control in adults with type 2 diabetes, and lowering heart risk in those at high risk.
Label against label
| Compared | Ozempic | Rybelsus |
|---|---|---|
| Active ingredient | semaglutide | semaglutide |
| Class | GLP-1 receptor agonist | GLP-1 receptor agonist |
| Maker | Novo Nordisk | Novo Nordisk |
| Approved for | Type 2 diabetes; heart and kidney risk in type 2 diabetes | Type 2 diabetes; heart risk in type 2 diabetes |
| Forms | Multi-dose pen; Single-dose prefilled syringe; Tablet | Tablet |
| How often | once a week or once a day | once a day |
| Starting dose | 0.25 mg a week (injection); 1.5 mg a day (tablets) | 3 mg a day |
| Top dose on the label | 2 mg a week (injection); 9 mg a day (tablets) | 14 mg a day |
| Most reported side effect | Nausea, 20.3% on 1 mg (placebo 6.1%) | Nausea, 20% on 14 mg (placebo 6%) |
| Boxed warning | “RISK OF THYROID C-CELL TUMORS” | “RISK OF THYROID C-CELL TUMORS” |
| First approved | 2017 | 2019 |
Each label’s side-effect figure comes from its own trials, at its own doses and in its own patients; as the labels themselves say, rates from different trials can’t be compared directly.
The two dosing schedules
This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.
Ozempic injection, once a week
Ozempic tablets, once a day
Rybelsus, once a day

A missed dose, on each label
The research on the ingredient
Questions
Are Ozempic and Rybelsus the same drug?
They hold the same active ingredient, semaglutide, from Novo Nordisk. They are approved for different uses and come in different forms and doses.
What are Ozempic and Rybelsus approved for?
Ozempic is approved for blood sugar control in adults with type 2 diabetes, and lowering heart and kidney risks in some of them. Rybelsus is approved for blood sugar control in adults with type 2 diabetes, and lowering heart risk in those at high risk.
How often are Ozempic and Rybelsus taken?
Ozempic is taken once a week or once a day, as an injection or a tablet; Rybelsus once a day, as a tablet.
What are the dose ranges of Ozempic and Rybelsus?
On their labels, Ozempic runs 0.25 mg to 2 mg once a week or 1.5 mg to 9 mg once a day, and Rybelsus 3 mg to 14 mg once a day. A prescriber sets the actual dose.
What is the most common side effect of Ozempic and Rybelsus?
On Ozempic’s label: nausea, 20.3% on 1 mg (placebo 6.1%). On Rybelsus’s: nausea, 20% on 14 mg (placebo 6%).
Sources
- OZEMPIC (semaglutide) injection, for subcutaneous use, FDA label on DailyMed (version 20, published Jun 10, 2026; read Nov 18, 2026)
- RYBELSUS (semaglutide) tablets and OZEMPIC (semaglutide) tablets, for oral use, FDA label on DailyMed (version 14, published Aug 19, 2026; read Nov 18, 2026)
- Drugs@FDA, NDA 209637 (Ozempic, the injection; application first approved 2017)
- Drugs@FDA, NDA 213051 (Ozempic, the tablets, added to the application by supplement 30 on Jan 30, 2026; application first approved 2019)
- Drugs@FDA, NDA 213051 (Rybelsus, the tablets; application first approved 2019)
PepVault is not affiliated with Novo Nordisk. Ozempic is a trademark of its owner. Rybelsus is a trademark of its owner.